
Profitability, historical returns, and peer comparisons.
According to KPC Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -5.62%. This represents a change of 286.19% compared to the average of -1.46% of the last 4 quarters.
The mean historical ROE of KPC Pharmaceuticals, Inc. over the last ten years is 9.57%. The current -5.62% ROE has changed -158.71% with respect to the historical average. Over the past ten years (40 quarters), 600422.SS's ROE was at its highest in in the December 2024 quarter at 4.96%. The ROE was at its lowest in in the June 2026 quarter at -4.57%.
Average
9.57%
Median
9.63%
Minimum
6.53%
Maximum
12.34%
Discovering the peaks and valleys of KPC Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 49.72%
Maximum Annual ROE = 12.34%
Minimum Annual Increase = -47.10%
Minimum Annual ROE = 6.53%
| Year | ROE | Change |
|---|---|---|
| 2025 | 6.53% | -47.10% |
| 2024 | 12.34% | 49.72% |
| 2023 | 8.24% | 7.15% |
| 2022 | 7.69% | -27.55% |
| 2021 | 10.61% | 3.39% |
| 2020 | 10.26% | -5.19% |
| 2019 | 10.83% | 23.28% |
| 2018 | 8.78% | -2.47% |
| 2017 | 9.00% | -21.34% |
| 2016 | 11.45% | -9.92% |
The current ROE of KPC Pharmaceuticals, Inc. (600422.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
9.03%
5-year avg
9.08%
10-year avg
9.57%
KPC Pharmaceuticals, Inc.’s ROE is less than Cisen Pharmaceutical Co., Ltd. (6.13%), less than Tianjin Ringpu Bio-Technology Co.,Ltd. (7.09%), less than Harbin Pharmaceutical Group Co., Ltd. (10.58%), less than Shandong Xinhua Pharmaceutical Company Limited (4.32%), less than North China Pharmaceutical Company Ltd. (1.62%), greater than Zhejiang Hisoar Pharmaceutical Co., Ltd. (-4.83%), less than Zhejiang Xianju Pharmaceutical Co.,Ltd. (7.76%), less than Renhe Pharmacy Co., Ltd. (6.02%), less than Changzhou Qianhong Biopharma CO.,LTD (8.27%), less than Northeast Pharmaceutical Group Co., Ltd. (3.42%),
| Company | ROE | Market cap |
|---|---|---|
| 6.13% | $5.76B | |
| 7.09% | $7.71B | |
| 10.58% | $12.62B | |
| 4.32% | $6.11B | |
| 1.62% | $7.53B | |
| -4.83% | $9.34B | |
| 7.76% | $8.60B | |
| 6.02% | $6.81B | |
| 8.27% | $7.77B | |
| 3.42% | $6.19B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like KPC Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like KPC Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is KPC Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for KPC Pharmaceuticals, Inc. (600422.SS)?
What is the highest ROE for KPC Pharmaceuticals, Inc. (600422.SS)?
What is the 3-year average ROE for KPC Pharmaceuticals, Inc. (600422.SS)?
What is the 5-year average ROE for KPC Pharmaceuticals, Inc. (600422.SS)?
How does the current ROE for KPC Pharmaceuticals, Inc. (600422.SS) compare to its historical average?